The U.S. Department of Defense said in a new memorandum that it is halting medical treatments and procedures for troops who identify as transgender and other personnel with gender dysphoria (GD).
“Apart from consults for the diagnosis of GD and provision of mental health care and counseling ... staff will refer all other care (e.g., cross-sex hormone therapy) for GD to the private sector.”
The Pentagon did not return a request for comment by publication time.
GD refers to when a person believes they’re a gender that’s different from their sex.
President Donald Trump, after taking office in January, said in an order that “expressing a false ‘gender identity’ divergent from an individual’s sex cannot satisfy the rigorous standards necessary for military service.”
Ferrara said in the new memo, which was sent to the director of the Defense Health Agency and assistant secretaries at the Army, Navy, and Air Force, that he was providing fresh guidance in light of the Supreme Court ruling.
That includes emphasizing that military doctors are not to perform any surgeries that would aid in gender transition, such as breast removal.
Ferrara also said that all unscheduled, scheduled, and planned surgical procedures “associated with facilitating sex reassignment for Service members diagnosed with GD” are now canceled, as are any previously approved waivers for the surgeries. Ferrara said his office would accept waiver requests for care deemed medically necessary to address surgical complications.
The military is allowing troops with GD who have been receiving cross-sex hormones to keep receiving them until they are separated, if a health care provider recommends that path “in order to prevent further complications.”
The Department of Defense, though, will no longer pay for newly initiated cross-sex hormones, according to the memo, as ordered by Defense Secretary Pete Hegseth.
